HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming Zhou Selected Research

6-methyladenine

1/2022Identification and Validation of N6-Methyladenosine-Related Biomarkers for Bladder Cancer: Implications for Immunotherapy.
1/2022The emerging roles of the interaction between m6A modification and c-Myc in driving tumorigenesis and development.
4/2021N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies.
1/2020m6A Reader YTHDC2 Promotes Radiotherapy Resistance of Nasopharyngeal Carcinoma via Activating IGF1R/AKT/S6 Signaling Axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming Zhou Research Topics

Disease

271Neoplasms (Cancer)
05/2024 - 07/2002
56Infections
04/2024 - 08/2005
53Neoplasm Metastasis (Metastasis)
11/2023 - 09/2002
48Nasopharyngeal Carcinoma
04/2024 - 01/2000
43Prostatic Neoplasms (Prostate Cancer)
09/2023 - 04/2002
34Carcinogenesis
03/2024 - 07/2003
33Breast Neoplasms (Breast Cancer)
05/2024 - 02/2010
33Carcinoma (Carcinomatosis)
01/2024 - 07/2003
32Inflammation (Inflammations)
04/2024 - 02/2002
28Renal Cell Carcinoma (Grawitz Tumor)
11/2023 - 07/2002
27Rabies (Hydrophobia)
02/2024 - 01/2013
17Aplastic Anemia (Anemia, Hypoplastic)
04/2024 - 07/2017
13Non-alcoholic Fatty Liver Disease
01/2024 - 11/2016
11COVID-19
12/2023 - 01/2020
11Body Weight (Weight, Body)
12/2022 - 06/2012
11Type 2 Diabetes Mellitus (MODY)
03/2019 - 01/2015
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 12/2018
9Hepatocellular Carcinoma (Hepatoma)
01/2021 - 07/2003
8Wounds and Injuries (Trauma)
04/2024 - 11/2011
8Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 09/2002
8Melanoma (Melanoma, Malignant)
10/2023 - 07/2002
8Adenocarcinoma
10/2022 - 03/2006
8Obesity
01/2021 - 08/2005
8Kidney Neoplasms (Kidney Cancer)
01/2016 - 11/2005
7Lymphatic Metastasis
12/2023 - 03/2006
7Cardiovascular Diseases (Cardiovascular Disease)
10/2023 - 02/2009
7Parkinson Disease (Parkinson's Disease)
01/2023 - 08/2009
7Ovarian Neoplasms (Ovarian Cancer)
10/2022 - 10/2011
7Glioma (Gliomas)
01/2022 - 10/2007
6Atherosclerosis
12/2023 - 01/2018
6Hypertension (High Blood Pressure)
05/2023 - 11/2015
6Disease Progression
01/2023 - 04/2009
6Prostatic Intraepithelial Neoplasia
10/2022 - 04/2002
6Epstein-Barr Virus Infections
10/2021 - 05/2006
5Virus Diseases (Viral Diseases)
03/2024 - 12/2017
5Ischemia
01/2024 - 12/2003
5Stomach Neoplasms (Stomach Cancer)
11/2023 - 11/2013
5Necrosis
06/2023 - 01/2004
5Hyperuricemia
11/2022 - 01/2020
5Glioblastoma (Glioblastoma Multiforme)
01/2022 - 10/2007
5Osteosarcoma (Osteogenic Sarcoma)
01/2021 - 04/2012

Drug/Important Bio-Agent (IBA)

97Proteins (Proteins, Gene)FDA Link
04/2024 - 04/2002
48Biomarkers (Surrogate Marker)IBA
01/2024 - 04/2002
37Long Noncoding RNAIBA
01/2023 - 01/2014
36Messenger RNA (mRNA)IBA
04/2024 - 04/2002
23MicroRNAs (MicroRNA)IBA
04/2023 - 04/2010
20RNA (Ribonucleic Acid)IBA
01/2024 - 05/2006
17Glucose (Dextrose)FDA LinkGeneric
01/2023 - 03/2015
15VaccinesIBA
12/2023 - 02/2009
15CytokinesIBA
01/2023 - 05/2005
14EnzymesIBA
05/2024 - 07/2004
14Paclitaxel (Taxol)FDA LinkGeneric
01/2024 - 02/2010
14DNA (Deoxyribonucleic Acid)IBA
01/2024 - 04/2002
13Circular RNAIBA
04/2024 - 01/2017
13Cisplatin (Platino)FDA LinkGeneric
05/2023 - 10/2011
12Keratins (Keratin)IBA
08/2023 - 09/2002
11Antiviral Agents (Antivirals)IBA
05/2024 - 01/2016
11Hormones (Hormone)IBA
05/2024 - 09/2002
11Phosphotransferases (Kinase)IBA
01/2024 - 02/2010
11Prostate-Specific Antigen (Semenogelase)IBA
09/2023 - 08/2007
10Complementary DNA (cDNA)IBA
08/2015 - 01/2000
9Transcription Factors (Transcription Factor)IBA
08/2023 - 02/2008
9ParaffinIBA
10/2022 - 07/2003
8Estrogens (Estrogen)FDA Link
05/2024 - 01/2009
8CholesterolIBA
01/2024 - 01/2018
8Peptides (Polypeptides)IBA
04/2023 - 10/2013
7AntigensIBA
05/2024 - 08/2007
7Anti-Bacterial Agents (Antibiotics)IBA
04/2024 - 03/2008
7LipidsIBA
03/2024 - 08/2015
7Estrogen ReceptorsIBA
01/2024 - 01/2009
7RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2024 - 01/2014
7Therapeutic UsesIBA
01/2024 - 04/2012
7Glycoproteins (Glycoprotein)IBA
12/2023 - 01/2012
7AntioxidantsIBA
09/2023 - 06/2010
7Competitive Endogenous RNAIBA
01/2022 - 12/2013
7AntibodiesIBA
01/2020 - 03/2003
6Carrier Proteins (Binding Protein)IBA
01/2024 - 01/2014
6AcidsIBA
10/2023 - 04/2006
6Uric Acid (Urate)IBA
01/2023 - 08/2016
6trans-sodium crocetinate (crocetin)IBA
10/2022 - 02/2009
6Neutralizing AntibodiesIBA
11/2021 - 02/2010
6Phenobarbital (Luminal)FDA Link
01/2021 - 01/2015
6Immunoglobulins (Immunoglobulin)IBA
01/2019 - 03/2010
5AndrogensIBA
05/2024 - 12/2004
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2023 - 09/2008
5Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2023 - 01/2019
5InterferonsIBA
12/2022 - 08/2011
5ProteomeIBA
10/2022 - 03/2004
5UbiquitinIBA
01/2022 - 12/2007
5Thyroid HormonesIBA
01/2022 - 01/2017

Therapy/Procedure

80Therapeutics
04/2024 - 07/2004
25Drug Therapy (Chemotherapy)
01/2024 - 09/2007
23Prostatectomy (Retropubic Prostatectomy)
08/2020 - 02/2004
16Immunotherapy
01/2024 - 01/2009
15Hematopoietic Stem Cell Transplantation
03/2024 - 07/2017
11Transplantation
04/2024 - 01/2017
9Nephrectomy
02/2019 - 08/2007
6Radiotherapy
04/2024 - 10/2002
5Aftercare (After-Treatment)
01/2024 - 08/2009
5Neoadjuvant Therapy
11/2023 - 10/2007